XT
BCRX icon

XTX Topco’s BioCryst Pharmaceuticals BCRX Stock Holding History

XTX Topco’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Buy
24,762
+7,651
+45% +$59.4K ﹤0.01% 2714
2025
Q4 		$133K Buy
+17,111
New +$124K ﹤0.01% 2550
2025
Q3 		– Sell
-95,201
Closed -$853K – 2569
2025
Q2 		$853K Buy
95,201
+7,812
+9% +$72.8K 0.04% 759
2025
Q1 		$655K Buy
87,389
+66,320
+315% +$535K 0.03% 827
2024
Q4 		$158K Sell
21,069
-10,601
-33% -$80.5K 0.01% 1644
2024
Q3 		$241K Sell
31,670
-125,276
-80% -$952K 0.02% 1331
2024
Q2 		$970K Buy
156,946
+117,607
+299% +$649K 0.08% 368
2024
Q1 		$200K Sell
39,339
-17,065
-30% -$96K 0.03% 1179
2023
Q4 		$338K Buy
56,404
+24,571
+77% +$142K 0.07% 532
2023
Q3 		$225K Sell
31,833
-69,112
-68% -$497K 0.04% 947
2023
Q2 		$711K Buy
100,945
+61,166
+154% +$491K 0.13% 199
2023
Q1 		$332K Buy
+39,779
New +$383K 0.07% 576
2022
Q3 		– Sell
-15,988
Closed -$169K – 1105
2022
Q2 		$169K Buy
+15,988
New +$165K 0.07% 509

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return